SCHEMBL8970624

SCHEMBL8970624

CCOc1ccc(-c2ccc(-c3ccc(COC4CCCCC4)cc3F)cc2)c(F)c1F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 6/20 0.41
NAAA Q02083 4/20 0.41
SIGMAR1 Q99720 6/20 0.40
TMEM97 Q5BJF2 4/20 0.40
APP P05067 1/20 0.38
FFAR4 Q5NUL3 1/20 0.36
MAPT P10636 2/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CHKA P35790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8969193 0.83 FFAR4 (0.41) FFAR4MAPTALDH1A1LMNAHPGD
SCHEMBL13000014 0.80 GRM2 (0.34) DRD4NAAASIGMAR1TMEM97FFAR4
SCHEMBL10303329 0.80 FGFR2 (0.39) NAAAFFAR4MAPTALDH1A1HPGD
SCHEMBL9019618 0.80 CYP3A4 (0.46) NAAAAPPFFAR4MAPTALDH1A1
SCHEMBL12740329 0.80 NAAA (0.40) DRD4NAAASIGMAR1TMEM97FFAR4
SCHEMBL15381751 0.80 HTR6 (0.38) DRD4NAAASIGMAR1TMEM97
SCHEMBL8972234 0.79 CYP3A4 (0.40) NAAAAPPMAPTALDH1A1LMNA
SCHEMBL8971183 0.79 APP (0.42) APPFFAR4MAPTALDH1A1LMNA
SCHEMBL14766979 0.79 FFAR1 (0.41) DRD4NAAASIGMAR1TMEM97FFAR4
SCHEMBL12740336 0.79 SIGMAR1 (0.43) DRD4NAAASIGMAR1TMEM97FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, HCN3, FZD7 DRD4 76/4885NAAA 4128/4885SIGMAR1 2375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.